Track record
Joseph Edelman
An officer, director or large holder of 8 blank-check companies. Every role below was declared by Joseph Edelman in an SEC ownership filing.
Vehicles
8
Still live
0
Closed a deal
7 of 8
Capital involved
$791M
Every vehicle, newest first
- Adagio Medical Holdings, Inc.ADGM · 10% holder · IPO Aug 1, 2024Completed
- Freenome, Inc.FRNM · Director · IPO Jun 12, 2024$85.1MCompleted
- ARYA Sciences Acquisition Corp V— · Director · IPO Jul 14, 2021$153MLiquidated
- ARYA Sciences Acquisition Corp IV— · Director · IPO Mar 1, 2021$37.1MCompleted
- Nautilus Biotechnology, Inc.NAUT · Director · IPO Aug 10, 2020$150MCompleted
- Orchestra BioMed Holdings, Inc.OBIO · 10% holder · IPO Aug 5, 2020$67.8MCompleted
- Cerevel Therapeutics Holdings, Inc.— · Director · IPO Jun 8, 2020$150MCompleted
- ARYA SCIENCES ACQUISITION CORP.— · Director · IPO Oct 9, 2018$149MCompleted
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1164426. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.